Retraction: Pioglitazone, a PPARγ Agonist, Suppresses CYP19 Transcription: Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA1.
Saved in:
| Title: | Retraction: Pioglitazone, a PPARγ Agonist, Suppresses CYP19 Transcription: Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA1. |
|---|---|
| Authors: | Subbaramaiah K, Howe LR, Zhou XK, Yang P, Hudis CA, Kopelovich L, Dannenberg AJ |
| Source: | Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2022 Jun 02; Vol. 15 (6), pp. 411. |
| Publication Type: | Journal Article; Retraction Notice |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101479409 Publication Model: Print Cited Medium: Internet ISSN: 1940-6215 (Electronic) Linking ISSN: 19406215 NLM ISO Abbreviation: Cancer Prev Res (Phila) Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35652223 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Retraction: Pioglitazone, a PPARγ Agonist, Suppresses CYP19 Transcription: Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA1. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Subbaramaiah+K%22">Subbaramaiah K</searchLink><br /><searchLink fieldCode="AU" term="%22Howe+LR%22">Howe LR</searchLink><br /><searchLink fieldCode="AU" term="%22Zhou+XK%22">Zhou XK</searchLink><br /><searchLink fieldCode="AU" term="%22Yang+P%22">Yang P</searchLink><br /><searchLink fieldCode="AU" term="%22Hudis+CA%22">Hudis CA</searchLink><br /><searchLink fieldCode="AU" term="%22Kopelovich+L%22">Kopelovich L</searchLink><br /><searchLink fieldCode="AU" term="%22Dannenberg+AJ%22">Dannenberg AJ</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101479409%22">Cancer prevention research (Philadelphia, Pa.)</searchLink> [Cancer Prev Res (Phila)] 2022 Jun 02; Vol. 15 (6), pp. 411. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Retraction Notice – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101479409 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1940-6215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219406215%22">19406215 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Prev Res (Phila) <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35652223 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1940-6207.CAPR-22-0204 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 411 Titles: – TitleFull: Retraction: Pioglitazone, a PPARγ Agonist, Suppresses CYP19 Transcription: Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA1. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Subbaramaiah K – PersonEntity: Name: NameFull: Howe LR – PersonEntity: Name: NameFull: Zhou XK – PersonEntity: Name: NameFull: Yang P – PersonEntity: Name: NameFull: Hudis CA – PersonEntity: Name: NameFull: Kopelovich L – PersonEntity: Name: NameFull: Dannenberg AJ IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 06 Text: 2022 Jun 02 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1940-6215 Numbering: – Type: volume Value: 15 – Type: issue Value: 6 Titles: – TitleFull: Cancer prevention research (Philadelphia, Pa.) Type: main |
| ResultId | 1 |
